Literature DB >> 20512391

Serum human cartilage glycoprotein-39 in patients with systemic sclerosis: relationship to skin and articular manifestation.

Dominika Wcislo-Dziadecka1, Anna Kotulska, Ligia Brzezińska-Wcislo, Malgorzata Widuchowska, Anna Lis-Swiety, Magdalena Kopec-Medrek, Eugene J Kucharz.   

Abstract

Human cartilage glycoprotein-39 (HC gp-30) is a secretory protein of several types of cells including chondrocytes. It has been suggested to be a laboratory index of joint damage. Thirty-two patients with systemic sclerosis (SSc) and 22 age-matched controls were investigated. An increased serum HC gp-39 level was shown in SSc patients and was found to correlate with inflammatory indices. There was no correlation with modified Rodnan score, joint involvement, or duration of symptoms of SSc. The obtained results indicate for possible relationship of HCgp-39 to inflammation but do not suggest determination of HC gp-39 as clinically applicable index of articular involvement in SSc patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20512391     DOI: 10.1007/s10067-010-1462-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  8 in total

1.  Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions.

Authors:  K Vos; P Steenbakkers; A M Miltenburg; E Bos; M W van Den Heuvel; R A van Hogezand; R R de Vries; F C Breedveld; A M Boots
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

2.  Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destruction.

Authors:  J S Johansen; J R Kirwan; P A Price; M Sharif
Journal:  Scand J Rheumatol       Date:  2001       Impact factor: 3.641

3.  High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement.

Authors:  C Nordenbaek; J S Johansen; P Halberg; A Wiik; C Garbarsch; S Ullman; P A Price; S Jacobsen
Journal:  Scand J Rheumatol       Date:  2005 Jul-Aug       Impact factor: 3.641

4.  Serum human cartilage glycoprotein-39 levels in patients with systemic lupus erythematosus.

Authors:  Dominika Wcisło-Dziadecka; Anna Kotulska; Ligia Brzezińska-Wcisło; Eugeniusz J Kucharz; Anna Lis-Swiety; Grazyna Kamińska-Wiciorek
Journal:  Pol Arch Med Wewn       Date:  2009-12

5.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

6.  Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer.

Authors:  J S Johansen; C Cintin; M Jørgensen; C Kamby; P A Price
Journal:  Eur J Cancer       Date:  1995       Impact factor: 9.162

7.  Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family.

Authors:  B E Hakala; C White; A D Recklies
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

8.  Cross-sectional evaluation of YKL-40 serum concentrations in patients with systemic sclerosis. Relationship with clinical and serological aspects of disease.

Authors:  Giovanni La Montagna; Salvatore D'Angelo; Gabriele Valentini
Journal:  J Rheumatol       Date:  2003-10       Impact factor: 4.666

  8 in total
  2 in total

1.  Oncostatin M and its role in fibrosis.

Authors:  Lukasz Stawski; Maria Trojanowska
Journal:  Connect Tissue Res       Date:  2018-07-30       Impact factor: 3.417

2.  Cells from the skin of patients with systemic sclerosis secrete chitinase 3-like protein 1.

Authors:  Yuen Yee Ho; Murray Baron; Anneliese D Recklies; Peter J Roughley; John S Mort
Journal:  BBA Clin       Date:  2014-01-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.